Chargement en cours...
Histone Deacetylase Inhibitor Sensitizes Apoptosis-resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway
Modern immune therapies [PD-1/PD-L1 and CTLA-4 checkpoints blockade, and adoptive cell transfer (ACT)] have remarkably improved the response rates of metastatic melanoma. These modalities rely on the killing potential of cytotoxic T lymphocytes (CTL) as proximal mediator of anti-melanoma responses....
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4136528/ https://ncbi.nlm.nih.gov/pubmed/24639349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1302532 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|